GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
IM-MV 18-015_006 Erasmus MC A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A 26-05-2020 Vergunning verleend
IM-MV 18-017_004 Universitair Medisch Centrum Utrecht A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A 29-05-2020 Vergunning verleend
IM-MV 18-018_004 AMC A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Hemophilia A 05-06-2020 Vergunning verleend
IM-MV 18-020_004 UMCG A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A 26-05-2020 Vergunning verleend
IM-MV 20-002_000 Het Nederlands Kanker Instituut Use of autologous patient-derived T cells enriched from peripheral blood mononuclear cells (PBMCs) and transduced with a gamma-retroviral self-inactivating (SIN) vector expressing a second generation chimeric antigen receptor (CAR) with specificity for the oncofetal antigen Claudin6 (CLDN6) under control of an internal promoter in patients suffering from CLDN6-positive malignancies 25-06-2020 Vergunning verleend
IM-MV 20-003_000 AMC Clinical studies with MB‐CART2019.1, a product consisting of ex‐vivo lentiviral transduced T‐cells using a replication‐deficient lentiviral vector 17-06-2020 Vergunning verleend
IM-MV 20-004_000 UMCG Clinical studies with MB-CART2019.1, a product consisting of ex-vivo lentiviral transduced T-cells using a replication-deficient lentiviral vector Ontwerpbesluit genomen
IM-MV 20-005_000 Erasmus MC Use of autologous patient-derived T cells enriched from peripheral blood mononuclear cells (PBMCs) and transduced with a gamma-retroviral self-inactivating (SIN) vector expressing a second generation chimeric antigen receptor (CAR) with specificity for the oncofetal antigen Claudin6 (CLDN6) under control of an internal promoter in patients suffering from CLDN6-positive malignancies Ontwerpbesluit genomen
IM-MV 20-006_000 Erasmus MC Clinical studies with MB-CART2019.1, a product consisting of ex-vivo lentiviral transduced T-cells using a replication-deficient lentiviral vector Ontwerpbesluit genomen